skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A highly sensitive and selective viral protein detection method based on RNA oligonucleotide nanoparticle

Original Research

(2076) Views  (764) Full article downloads

Authors: Changhyun Roh, Ho-Young Lee, Sang-Eun Kim, et al

Published Date April 2010 Volume 2010:5 Pages 323 - 329
DOI: http://dx.doi.org/10.2147/IJN.S10134

Changhyun Roh1, Ho-Young Lee2, Sang-Eun Kim2, Sung-Kee Jo1

1Radiation Research Division for Biotechnology, Advanced Radiation Technology Institute (ARTI), Korea Atomic Energy Research Institute (KAERI), Sinjeong-dong, Jeongeup, Jeonbuk, South Korea; 2Department of Nuclear Medicine, College of Medicine, Seoul National University, South Korea

Abstract: Globally, approximately 170 million people (representing approximately 3% of the population worldwide), are infected with hepatitis C virus (HCV) and at risk of serious liver disease, including chronic hepatitis. We propose a new quantum dots (QDs)-supported RNA oligonucleotide approach for the specific and sensitive detection of viral protein using a biochip. This method was developed by immobilizing a HCV nonstructural protein 5B (NS5B) on the surface of a glass chip via the formation of a covalent bond between an amine protein group and a ProLinkerTM glass chip. The QDs-supported RNA oligonucleotide was conjugated via an amide formation reaction from coupling of a 5′-end-amine-modified RNA oligonucleotide on the surface of QDs displaying carboxyl groups via standard EDC coupling. The QDs-conjugated RNA oligonucleotide was interacted to immobilized viral protein NS5B on the biochip. The detection is based on the variation of signal of QDs-supported RNA oligonucleotide bound on an immobilized biochip. It was demonstrated that the value of the signal has a linear relationship with concentrations of the HCV NS5B viral protein in the 1 μg mL-1 to 1 ng mL-1 range with a detection limit of 1 ng mL-1. The major advantages of this RNA-oligonucleotide nanoparticle assay are its good specificity, ease of performance, and ability to perform one-spot monitoring. The proposed method could be used as a general method of HCV detection and is expected to be applicable to other types of diseases as well.

Keywords: hepatitis C virus, viral protein, RNA oligonucleotide, quantum dots, biochip






 

Other articles by Dr Changhyun Roh



Readers of this article also read:

Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
The effect of acetaminophen nanoparticles on liver toxicity in a rat model
Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus
Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies
Nanomedicine: promises and challenges for the future of public health
Amino acid management of Parkinson’s disease: a case study
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease